SCHEMBL5201379

SCHEMBL5201379

CC(CC#N)CCC#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24667370 0.86 TSHR (0.50)
SCHEMBL24196133 0.86 TSHR (0.50)
SCHEMBL9921701 0.85 TSHR (0.60)
SCHEMBL25891679 0.82
SCHEMBL1345692 0.82
SCHEMBL26316534 0.78
SCHEMBL4198593 0.78
SCHEMBL1342478 0.78
SCHEMBL1315582 0.78
SCHEMBL1603583 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111170870-B Synthesis method of 3-methyl-1, 6-hexamethylenediamine 安徽中羰碳一工业技术有限责任公司 2023-06-30 CN claimed
US-9230746-B2 Nonaqueous electrolytic solution and electrochemical device using the same UBE INDUSTRIES, LTD (JP) 2016-01-05 US claimed
EP-4667054-A2 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY Novartis AG (CH) 2025-12-24 EP disclosed
EP-3880660-B1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2025-07-02 EP disclosed
CN-113166065-B Compounds and compositions for treating disorders associated with NLRP activity 诺华股份有限公司 2025-04-15 CN disclosed
US-11799067-B2 Battery PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2023-10-24 US disclosed
CN-111170870-B Synthesis method of 3-methyl-1, 6-hexamethylenediamine 安徽中羰碳一工业技术有限责任公司 2023-06-30 CN disclosed
US-20230031406-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS AG (CH) 2023-02-02 US disclosed
EP-3880660-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY Novartis AG (CH) 2021-09-22 EP disclosed
CN-113166065-A Compounds and compositions for treating conditions associated with NLRP activity 诺华股份有限公司 2021-07-23 CN disclosed
US-20200411849-A1 BATTERY PANASONIC IP MAN CO LTD (JP) 2020-12-31 US disclosed
EP-1189876-A2 PROCESS FOR HYDROGENATING DINITRILES IN AMINONITRILES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2002-03-27 EP disclosed
US-20010047104-A1 Partial hydrogenation of a dinitrile by contacting with a hydrogen-containing fluid in an ammonium hydroxide solvent, a hydrogenation catalyst and additive tetraalkylammonium or phosphonium hydroxide; catalyst selectivity; efficiency INVISTA NORTH AMERICA S.A.R.L. 2001-11-29 US disclosed
US-6258745-B1 PARTIAL HYDROGENATION OF A DINITRILE USING CATALYST E. I. DU PONT DE NEMOURS AND COMPANY 2001-07-10 US disclosed
CN-1293657-A Aminonitrile production DU PONT (US) 2001-05-02 CN disclosed
EP-1062200-A1 AMINONITRILE PRODUCTION E.I. DU PONT DE NEMOURS AND COMPANY (US) 2000-12-27 EP disclosed
WO-2000064862-A2 PROCESS FOR HYDROGENATING DINITRILES IN AMINONITRILES E.I. DU PONT DE NEMOURS AND COMPANY (US) 2000-11-02 WO disclosed
US-6080884-A HYDROGENATING A DINITRILE WITH A HYDROGEN-CONTAINING FLUID IN THE PRESENCE OF A SOLVENT AND A METAL CATALYST; EFFICIENCY, BY-PRODUCT INHIBITION E. I. DU PONT DE NEMOURS AND COMPANY (US) 2000-06-27 US disclosed
US-5986127-A HYDROGENATION OF DINITRILE E. I. DU PONT DE NEMOURS AND COMPANY (US) 1999-11-16 US disclosed
WO-1999047492-A1 AMINONITRILE PRODUCTION E.I. DU PONT DE NEMOURS AND COMPANY (US) 1999-09-23 WO disclosed